The cost-effectiveness of hospital-based telephone coaching for people with type 2 diabetes: a 10 year modelling analysis.
Type 2 diabetes (T2DM) is a burdensome condition for individuals to live with and an increasingly costly condition for health services to treat. Cost-effective treatment strategies are required to delay the onset and slow the progression of diabetes related complications. The Diabetes Telephone Coaching Study (DTCS) demonstrated that telephone coaching is an intervention that may improve the risk factor status and diabetes management practices of people with T2DM. Measuring the cost effectiveness of this intervention is important to inform funding decisions that may facilitate the translation of this research into clinical practice. The purpose of this study is to assess the cost-effectiveness of telephone coaching, compared to usual diabetes care, in participants with poorly controlled T2DM.



A cost utility analysis was undertaken using the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model to extrapolate outcomes collected at 6 months in the DTCS over a 10 year time horizon. The intervention's impact on life expectancy, quality-adjusted life expectancy (QALE) and costs was estimated. Costs were reported from a health system perspective. A 5 % discount rate was applied to all future costs and effects. One-way sensitivity analyses were conducted to reflect uncertainty surrounding key input parameters.



The intervention dominated the control condition in the base-case analysis, contributing to cost savings of $3327 per participant, along with non-significant improvements in QALE (0.2 QALE) and life expectancy (0.3 years).



The cost of delivering the telephone coaching intervention continuously, for 10 years, was fully recovered through cost savings and a trend towards net health benefits. Findings of cost savings and net health benefits are rare and should prove attractive to decision makers who will determine whether this intervention is implemented into clinical practice.



ACTRN12609000075280.
Department of Gastroenterology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Level 6, The Alfred Centre, 99 Commercial Road, Melbourne, 3004, Australia. jane.varney@monash.edu.
J E
JE
Varney
Department of Epidemiology and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Level 6, The Alfred Centre, 99 Commercial Road, Melbourne, 3004, Australia.
D
D
Liew
St Vincent's Hospital, Melbourne and University of Melbourne, Melbourne, Australia.
T J
TJ
Weiland
Princess Alexandra Hospital and The University of Queensland, 199 Ipswich Road, Woolloongabba, QLD, 4102, Australia.
W J
WJ
Inder
University of Melbourne, Melbourne, Australia.
G A
GA
Jelinek
D000328:Adult; D003362:Cost-Benefit Analysis; D048909:Diabetes Complications / Q000097:blood / Q000191:economics / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000191:economics / Q000628:therapy*; D004469:Economics, Hospital; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D017048:Health Care Costs; D018575:Home Care Services, Hospital-Based / Q000191:economics*; D006801:Humans; D008297:Male; D000071252:Mentoring / Q000191:economics; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D011446:Prospective Studies; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D012307:Risk Factors; D017216:Telemedicine / Q000191:economics*; D013689:Telephone / Q000191:economics*; D006113:United Kingdom; D014739:Victoria
D006442:Glycated Hemoglobin
Cost-effectiveness; Telephone coaching; Type 2 diabetes
Circulation. 2003 May 20;107(19):2435-9
12719277
Med J Aust. 2006 Sep 18;185(6):305-9
16999670
Intern Med J. 2010 Apr;40(4):286-92
19323700
Am J Health Behav. 2010 Nov-Dec;34(6):750-63
20604699
Diabetologia. 2004 Oct;47(10 ):1747-59
15517152
Diabetes Care. 2004 Jan;27(1):17-20
14693960
Diabetes Care. 2005 Jun;28(6):1490-2
15920075
N Engl J Med. 2006 Oct 12;355(15):1563-71
17035649
J Consult Clin Psychol. 1988 Aug;56(4):529-34
2848874
Diabetes Care. 2012 Nov;35(11):2156-60
22851599
Ann Intern Med. 2001 Jan 16;134(2):96-105
11177312
Diabetes Res Clin Pract. 2011 Jan;91(1):121-6
21074286
Med Decis Making. 2002 Jul-Aug;22(4):340-9
12150599
J Adv Nurs. 2003 Nov;44(3):256-61
14641395
PLoS One. 2009;4(4):e5195
19365563
CMAJ. 1999 Oct 19;161(8):959-62
10551191
N Engl J Med. 2010 Sep 23;363(13):1245-55
20860506
Heart Lung Circ. 2009 Dec;18(6):388-92
19648058
N Engl J Med. 1993 Sep 30;329(14):977-86
8366922
Yonsei Med J. 2003 Feb;44(1):1-8
12619168
Diabetes Care. 2005 Feb;28(2):278-82
15677779
BMC Public Health. 2008 Jul 10;8:235
18616797
Ann Fam Med. 2008 Nov-Dec;6(6):512-8
19001303
Diabetes Care. 2004 Jan;27(1):83-8
14693971
Health Aff (Millwood). 2004 May-Jun;23(3):10-25
15160799
J Diabetes Complications. 2004 Mar-Apr;18(2):113-8
15120706
Ann Intern Med. 2000 Apr 18;132(8):605-11
10766678
Intern Med J. 2014 Sep;44(9):890-7
24963611
Am J Prev Med. 2012 Jan;42(1):81-8
22176852
Arch Intern Med. 2010 Sep 27;170(17):1566-75
20876408
Ann Intern Med. 1998 Oct 15;129(8):605-12
9786807
Diabetes Care. 1994 Aug;17(8):840-6
7956628
Clin Ophthalmol. 2008 Dec;2(4):763-8
19668428
J Diabetes Complications. 2016 Mar;30(2):300-5
26750743
Intern Med J. 2009 Aug;39(8):512-8
19220533
Value Health. 2008 Mar-Apr;11(2):199-206
18380631
PLoS One. 2009 Sep 25;4(9):e7135
19779611
Curr Med Res Opin. 2005 Oct;21(10):1617-29
16238902